Article
Towards accurate indel calling for oncopanel sequencing through an international pipeline competition at precisionFDA.
Scientific reports - 8 Apr 2024
Gong Binsheng, Lababidi Samir, Kusko Rebecca, Bouri Khaled, Prezek Sarah, Thovarai Vishal, Prasanna Anish, Maier Ezekiel J, Golkaram Mahdi, Sun Xingqiang, Kyriakidis Konstantinos, Kitajima João Paulo, Ebrahim Sahraeian Sayed Mohammad, Guo Yunfei, Johanson Elaine, Jones Wendell, Tong Weida, Xu Joshua
Abstract excerpt
Accurately calling indels with next-generation sequencing (NGS) data is critical for clinical application. The precisionFDA team collaborated with the U.S. Food and Drug Administration's (FDA's) National Center for Toxicological Research (NCTR) and successfully completed the NCTR Indel Calling from Oncopanel Sequencing Data Challenge, to evaluate the performance of indel calling pipelines. Top performers were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
